(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Vote in favor of Your Fantasy Vehicle: Which Notable Model Catches Your Heart? - 2Figuring out Significant Regulations and Guidelines for Organizations
- 3Vote In favor of Your Favored Comupter Game
- 4What's an atmospheric river? AP explains the weather phenomenon
- 5Turkey key underlying issue as Israel, Greece, Cyprus hold summit
- Finding the Force of Mentorship: Self-awareness Through Direction
- A Couple of Reasonable Guitars for 2024
- ‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- 2025 Was Another Exceptionally Hot Year
- 'Women on the floor, riddled with bullets': Ex-hostage Rom Braslavski recounts 'horrors' of Oct. 7
- Who is Adm. Frank 'Mitch' Bradley and what does he have to do with the Venezuela boat strikes?
- The many ways that baking is winter therapy. With a delicious ending
- Interstellar comet 3I/ATLAS isn't an alien spacecraft, astronomers confirm. 'In the end, there were no surprises.'
- Top notch Remote Earphones for Audiophiles
